Endocyte Competitors and Similar CompaniesClear all
Endocyte's competitors and similar companies include TScan Therapeutics and Century Therapeutics.
 Endocyte Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases. |  TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies. |  Century Therapeutics Century Therapeutics is a biotech company that develops therapies to treat cancer. | |
Founding Date | Founding Date 1995 | Founding Date 2018 | Founding Date 2018 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations West Lafayette, US HQ Saint Genis Pouilly, FR Indianapolis, US | Locations Waltham, US HQ | Locations Philadelphia, US HQ Hamilton, CA Seattle, US |
Employees | Employees 476% decrease | Employees 7316% increase | Employees 107 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 251.6 m | Valuation ($) 115.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) $70k (FY, 2017) | Revenue (est.) $10.3m (FY, 2025) | Revenue (est.) $109.2m (FY, 2025) |
Net income | Net income ($55.1m) (FY, 2017) | Net income ($129.8m) (FY, 2025) | Net income ($9.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 41m | Total funding raised $ 137.5m | Total funding raised $ 410m |
For sources of this data, please see the company profile
View Company Profiles
TScan Therapeutics
HQ
Waltham, US
Employees
73↑ 16% increase
TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
View companyCentury Therapeutics
HQ
Philadelphia, US
Employees
107
Century Therapeutics is a biotech company that develops therapies to treat cancer.
View company